Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
28972 | 160 | 22.7 | 49% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1301 | 8126 | ANTIPHOSPHOLIPID SYNDROME//ANTIPHOSPHOLIPID ANTIBODIES//LUPUS ANTICOAGULANT |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CRYOFIBRINOGEN | Author keyword | 21 | 78% | 9% | 14 |
2 | CRYOFIBRINOGENEMIA | Author keyword | 17 | 70% | 9% | 14 |
3 | CRYOFIBRINOGENAEMIA | Author keyword | 12 | 86% | 4% | 6 |
4 | HYPERGAMMAGLOBULINEMIC PURPURA | Author keyword | 6 | 100% | 3% | 4 |
5 | CRYOPROTEINS | Author keyword | 5 | 63% | 3% | 5 |
6 | ABT TRANSFUS MED ZELLTHER EUTIKA HAMOSTASEOL | Address | 1 | 50% | 1% | 1 |
7 | CD62P SELECTIN | Author keyword | 1 | 50% | 1% | 1 |
8 | CRYOPRECIPITATES | Author keyword | 1 | 50% | 1% | 1 |
9 | DIGITAL ULCERATION | Author keyword | 1 | 50% | 1% | 1 |
10 | IGG RHEUMATOID FACTORS | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CRYOFIBRINOGEN | 21 | 78% | 9% | 14 | Search CRYOFIBRINOGEN | Search CRYOFIBRINOGEN |
2 | CRYOFIBRINOGENEMIA | 17 | 70% | 9% | 14 | Search CRYOFIBRINOGENEMIA | Search CRYOFIBRINOGENEMIA |
3 | CRYOFIBRINOGENAEMIA | 12 | 86% | 4% | 6 | Search CRYOFIBRINOGENAEMIA | Search CRYOFIBRINOGENAEMIA |
4 | HYPERGAMMAGLOBULINEMIC PURPURA | 6 | 100% | 3% | 4 | Search HYPERGAMMAGLOBULINEMIC+PURPURA | Search HYPERGAMMAGLOBULINEMIC+PURPURA |
5 | CRYOPROTEINS | 5 | 63% | 3% | 5 | Search CRYOPROTEINS | Search CRYOPROTEINS |
6 | CD62P SELECTIN | 1 | 50% | 1% | 1 | Search CD62P+SELECTIN | Search CD62P+SELECTIN |
7 | CRYOPRECIPITATES | 1 | 50% | 1% | 1 | Search CRYOPRECIPITATES | Search CRYOPRECIPITATES |
8 | DIGITAL ULCERATION | 1 | 50% | 1% | 1 | Search DIGITAL+ULCERATION | Search DIGITAL+ULCERATION |
9 | IGG RHEUMATOID FACTORS | 1 | 50% | 1% | 1 | Search IGG+RHEUMATOID+FACTORS | Search IGG+RHEUMATOID+FACTORS |
10 | CRYOPATHY | 0 | 33% | 1% | 1 | Search CRYOPATHY | Search CRYOPATHY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STANOZOLOL | 3 | 14% | 12% | 19 |
2 | CRYOFIBRINOGENEMIA | 2 | 26% | 3% | 5 |
3 | ANTI ROSSA | 1 | 100% | 1% | 2 |
4 | RESISTANCE SYNDROMES | 1 | 33% | 1% | 2 |
5 | FUROSEMIDE WITHDRAWAL | 1 | 50% | 1% | 1 |
6 | INTRAMUSCULAR STANOZOLOL | 1 | 50% | 1% | 1 |
7 | WALDENSTROM | 1 | 25% | 1% | 2 |
8 | HEPARIN PRECIPITABLE FRACTION | 0 | 33% | 1% | 1 |
9 | FIBRINOLYTIC ENHANCEMENT | 0 | 11% | 2% | 3 |
10 | THYROID CELL PROLIFERATION | 0 | 15% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
An approach to the diagnosis and treatment of cryofibrinogenemia | 2004 | 31 | 11 | 91% |
A 5-year prospective follow-up study in essential cryofibrinogenemia patients | 2011 | 8 | 18 | 83% |
Cryofibrinogenemia | 2013 | 10 | 30 | 83% |
Hypergammaglobulinemic purpura of Waldenstrom: Report of 3 cases with a short review | 2000 | 5 | 12 | 83% |
HYPERGAMMAGLOBULINEMIC PURPURA IN CHILDHOOD - REPORT OF 2 CASES AND REVIEW OF THE LITERATURE | 1988 | 4 | 5 | 100% |
BENIGN HYPERGAMMAGLOBULINEMIC PURPURA OF WALDENSTROM ASSOCIATED WITH SJOGRENS-SYNDROME - CASE-REPORT AND REVIEW OF IMMUNOLOGICAL ASPECTS | 1986 | 25 | 11 | 27% |
DANAZOL | 1989 | 6 | 31 | 13% |
Update endocrinology .2. | 1996 | 0 | 137 | 4% |
Update endocrinology .2. | 1996 | 0 | 133 | 4% |
Possible genetic reasons for late complications in diabetes mellitus | 2000 | 2 | 76 | 1% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABT TRANSFUS MED ZELLTHER EUTIKA HAMOSTASEOL | 1 | 50% | 0.6% | 1 |
2 | MANNHEIM GERONTOPHARMACOL | 1 | 50% | 0.6% | 1 |
3 | PERIPHERAL HISTOCOMPATIBIL | 1 | 50% | 0.6% | 1 |
4 | REFERENCES MALAD AUTOIMMUNES | 0 | 33% | 0.6% | 1 |
5 | KLINIKUM CHEMNITZ | 0 | 20% | 0.6% | 1 |
6 | MED DERMATOL SERV | 0 | 14% | 0.6% | 1 |
7 | PEDIAT MBC58 | 0 | 14% | 0.6% | 1 |
8 | CNRS UMR 7211 | 0 | 11% | 0.6% | 1 |
9 | HOSPITALIST SECT | 0 | 11% | 0.6% | 1 |
10 | SECT TRANSPLANT IMMUNOL | 0 | 11% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000131172 | CRYOGLOBULINEMIA//MIXED CRYOGLOBULINEMIA//CRYOGLOBULINAEMIA |
2 | 0.0000127404 | SNEDDONS SYNDROME//SNEDDON SYNDROME//LIVEDOID VASCULOPATHY |
3 | 0.0000081690 | PROTEIN S//PROTEIN C DEFICIENCY//C4B BINDING PROTEIN |
4 | 0.0000072438 | PLASMINOGEN ACTIVATOR INHIBITION//PLASMIN INHIBITION//T PA ANTIGEN |
5 | 0.0000065240 | HEPARIN COFACTOR II//ANTITHROMBIN//ANTITHROMBIN DEFICIENCY |
6 | 0.0000058640 | CALCIPHYLAXIS//CALCIFIC UREMIC ARTERIOLOPATHY//CALCIFIC URAEMIC ARTERIOLOPATHY |
7 | 0.0000051913 | HENOCH SCHONLEIN PURPURA//LEUKOCYTOCLASTIC VASCULITIS//HENOCH SCHONLEIN PURPURA NEPHRITIS |
8 | 0.0000051641 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA |
9 | 0.0000049084 | PIGMENTED PURPURIC DERMATOSIS//PIGMENTED PURPURIC DERMATOSES//PIGMENTED PURPURA |
10 | 0.0000047916 | MASTALGIA//CYCLICAL MASTALGIA//BREAST PAIN |